Byetta (Exenatide)

Byetta (Exenatide) is for people with type 2 diabetes
Byetta (Exenatide) is for people with type 2 diabetes

Byetta (generic name Exenatide) is used to treat people with type 2 diabetes. Byetta is an injectable drug that helps to lower blood sugar levels by acting as an incretin mimetic.

Byetta is not insulin, but it is one of a new class of diabetic drugs called incretin mimetics.

How does Byetta work?

Byetta works by increasing the secretion of insulin from the pancreas, reducing glucagons action and slowing the absorption of glucose from the gut.

Together, these actions lower blood sugar levels and make Byetta efficient in lowering blood glucose levels.

This drug type, based on human-glucagon-like peptide-1 (GLP-1) also serve to reduce appetite.

Is Exenatide naturally occurring?

Exenatide is a man-made hormone that mimics the action of the naturally occurring hormone GLP-1.

Patients treated with Exenatide have been proven to achieve lower blood glucose levels.

Who is Byetta (exenatide) prescribed to?

Exenatide is typically prescribed with other drugs, and is used to reduce blood glucose levels amongst patients with type 2 diabetes who cannot achieve stable blood glucose by taking metformin, or metformin in combination with other drugs.

Exenatide is not usually prescribed to patients with type 1 diabetes, and it is not a substitute for daily insulin injections.

How does one take Byetta (exenatide)?

Byetta is taken by subcutaneous injection twice per day, usually an hour before breakfast and dinner.

Doses are typically injected into the thigh, abdomen or upper arm.

What are the side effects of Byetta (Exenatide)?

Byetta side effects include nausea, hypoglycaemia, vomiting, diarrhoea, headache, nervousness and stomach pain.

Exenatide can also lead to lower appetite, acid reflux and sweating.

I want to know more about Exenatide, what should I do?

If your question is urgent, contact your doctor or a healthcare professional immediately. Feel free to use the forum to get an independent perspective from the community.

Explore Byetta
Join the Diabetes Newsletter

Join us